Frontlight ResearchEarly access
Trial site
Fed State Budgetary Inst "N.N. Blokhin Med Center of Oncology" MHRF
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer2 trials
- Childhood cancers1 trial
- Thyroid cancer1 trial
- Phase
- Phase 33 trials
- Status
- Active, not recruiting3 trials
- Lead sponsor
- Eli Lilly and Company2 trials
- Loxo Oncology, Inc.1 trial
Running trials
Active, not recruiting
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Active, not recruiting
Active, not recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026